Dr. Peter A. McCullough discusses censorship he faced over four years and introduces Dr. Philip McMillan, a key figure in autoimmune research related to Covid-19 and long-term symptoms. McMillan, a physician and researcher, emphasizes understanding complex diseases, proposing that severe Covid-19 involves an autoimmune response. His work, supported by research at Johns Hopkins, seeks solutions for various inflammatory conditions and promotes collaboration among experts through public outreach. McCullough encourages support for his publication to further truth in healthcare.
Vilification of Dr. McCullough as He Searches for Solutions Pressing Issues of Early Treatment and Vaccine Detoxification Require Focus Free of Distractions Thu, 17 Oct 2024 09:45:26 GMT https://petermcculloughmd.substack.com/p/vilification-of-dr-mccullough-as By Peter A. McCullough, MD, MPH
I have not given routine updates on censorship activities that have plagued me over the past four years, but I did open up to Dr. McMillan from the UK as it was his interview.
Dr. Philip McMillan and Dr Peter McCullough in Whitby, Ontario, September, 2024
About Dr Philip McMillan, MB BS, MRCP(UK) of the Vejon Consultive
Dr Philip McMillan is a physician, researcher and international keynote speaker with an innovative approach to the development of solutions for autoimmune disorders, subclinical inflammation, long haul disease and long-term Covid symptoms.
He was the first to outline a theory of autoimmunity in Covid-19, and he shares valuable research on science and health through published papers and social media. He hosts a series of panels and conferences which bring together international experts on Covid-19 and long Covid. He also interviews a broad range of global experts, reaching over 15 million views on social media.
Dr McMillan’s work on long haul disease is a natural evolution of his research on autoimmunity in Covid-19. Through collaboration with specialists such as Dr Bruce Patterson, he has advanced the understanding and treatment of long haulers.
He focuses on identifying the primary drivers for subclinical inflammation and incorporates this into his clinical practice. Dr McMillan applies new thinking to the development of solutions for his patients and, in the process, hopes to uncover critical links to chronic fatigue syndrome (CFS).
Dr McMillan applies his research technique to improving the understanding of complex disease. He has observed that the primary pathology of a disease is typically several steps away from the visible symptoms. In the case of Covid-19, he proposed that severe disease is a viral-mediated autoimmune response. In April 2020, Dr McMillan first outlined the theory of autoimmunity in Covid-19 which was based on the interaction between the viral spike protein and serum ACE-2, and was subsequently published in a paper co-authored by Prof Bruce Uhal, the top pulmonary ACE-2 researcher globally. Research at Johns Hopkins University has since (October 2020) confirmed autoantibodies to ACE-2 in the serum of severely affected patients, supporting the theory of autoimmunity in Covid-19.
Dr McMillan is the founder of the Vejon Health Group of Companies which focuses on research into complex medical conditions, with the goal of finding solutions for inflammatory conditions, Covid-19, long haul disease, dementia, osteoporosis and type 2 diabetes.
Please enjoy his work as a fearless physician and journalist who has been reporting on the issues of censorship and professional reprisal of doctors, nurses, and other healthcare personnel as they attempt to help patients through two waves of pandemic injury—SARS-CoV-2 infection and COVID-19 vaccination.
Courageous Discourse™ with Dr. Peter McCullough & John Leake is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation